BELLEVUE, Wash., July 29 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (Amex: DDD) today announced plans to release second quarter 2008 financial results on Thursday, August 7, 2008, at 8:30 a.m. Eastern. Daniel O. Wilds, President and CEO of SCOLR Pharma, will host a conference call at 11:30 a.m. Eastern, to discuss the results.
Shareholders and other interested parties may participate in the conference call by dialing +1 888 680 0878 (domestic) or +1 617 213 4855 (international) and entering access code 26733631, a few minutes before 11:30 a.m. ET on August 7, 2008. The call will also be broadcast live on the Internet at http://www.streetevents.com, http://www.fulldisclosure.com or http://www.scolr.com.
A replay of the conference call will be accessible two hours after its completion through August 21, 2008, by dialing +1 888 286 8010 (domestic) or +1 617 801 6888 (international) and entering access code 55141034. The call will also be archived for 90 days at http://www.streetevents.com, http://www.fulldisclosure.com or http://www.scolr.com.
Based in Bellevue, Washington, SCOLR Pharma, Inc. is a specialty
pharmaceutical company. SCOLR Pharma's corporate objective is to combine
its formulation expertise and its patented CDT platform to develop novel
pharmaceutical, over-the-counter (OTC), and nutritional products. Our CDT
drug delivery platform is based on multiple issued and pending patents and
other intellectual property for the programmed release or enhanced
performance of active pharmaceutical ingredients and nutritional products.
For more information on SCOLR Pharma, please call 425.373.0171 or visit
|SOURCE SCOLR Pharma, Inc.|
Copyright©2008 PR Newswire.
All rights reserved